World Emerging Stem Cell Market


USD 1,450.00

* Required Fields

USD 1,450.00


Be the first to review this product

The purpose of this report is to provide a concise and updated paper on the international legislation and research initiatives involving stem cells. The report outlines both adult and embryonic/fetal stem cells in order to provide a comparison of the two technologies which compete for the same sources of funding. In addition, the report provides an overview of the disease applications that may be treated by stem cells in the future, along with their economic cost where possible. The major players and their activities and current clinical research are also discussed.

Table of Contents

World Emerging Stem Cell Market, Executive SummaryExecutive SummaryPowerPoint PresentationWorld Emerging Stem Cell Market, Total MarketOverviewIntroductionThe US Federal Government on Stem CellsStem Cell Legislation Around The WorldCurrent Clinical ProgressChallengesDemand for Stem Cell TherapiesDiabetesDiseases of the Central Nervous SystemOrgan TransplantsOther Disease ApplicationsResearch Applications for Stem CellsCompetitive AnalysisPrivate and Public FundingEmbryonic and Fetal Stem Cell Research CompaniesAdult Stem Cell Research CompaniesStrategic AlliancesLocation of Stem Cell Lines

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.